Audit of the Biologics and Radiopharmaceutical Drugs Program at Health Canada, June 2018.: H14-604/2018E-PDF
"We examined the management control framework related to the Biologics and Radiopharmaceutical Drugs Program (BRDP or the Program). The audit focused on governance, risk management, and internal controls..."--Executive Summary, page [4].
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.937142&sl=0
| Department/Agency | Canada. Health Canada, issuing body. Public Health Agency of Canada, issuing body. |
|---|---|
| Title | Audit of the Biologics and Radiopharmaceutical Drugs Program at Health Canada, June 2018. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document |
|
| Note(s) | Issued also in French under title: Audit du programme des produits biologiques et radiopharmaceutiques de Santé Canada, juin 2018. "Final report presented to the Departmental Audit Committee, June 20, 2018." |
| Publishing information | [Ottawa] : Health Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, June 20, 2018. |
| Description | 1 online resource (27 unnumbered pages) + management response and action plan (5 unnumbered pages) |
| Catalogue number |
|
| Subject terms | Canada. Health Canada -- Auditing. Public Health Agency of Canada -- Auditing. Biologicals -- Canada -- Auditing. |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: